Published in Physician Law Weekly, October 11th, 2006
Study 1: Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption.
Researchers in Spain conducted a study "to analyze the predictive capacity of thymic volume in CD4 T-cell loss after treatment interruption in HIV-infected patients with high nadir CD4 count."
"Thirty-nine HIV-infected patients with CD4 counts {{>=}}500 cells/microliter, nadir CD4 counts {{>=}}250 cells/microliter, and plasma viral loads <50 copies/mL for at least the past 12 months began a treatment interruption program....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-10-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.